U.S. Markets open in 9 hrs 18 mins

Pharmaceutical Segment: A Key Revenue Driver for JNJ in Q1

Margaret Patrick
Pharmaceutical Segment: A Key Revenue Driver for JNJ in Q1

Is Johnson & Johnson an Attractive Buy following Its Q1 Results?(Continued from Prior Part)Financial performanceIn the first quarter, Johnson & Johnson’s (JNJ) Pharmaceutical segment reported 7.9% YoY (year-over-year) growth in worldwide